Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Fuji
Accenture
McKinsey
McKesson
Daiichi Sankyo
Citi
US Army
Dow

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,083,809

« Back to Dashboard

Summary for Patent: 7,083,809
Title:Purified cytokine inhibitory factor
Abstract: Disclosed is a composition comprising a substantially purified Cytokine Inhibitory Factor (CIF) having certain characteristics, including the ability to inhibit RNA transcription of the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-.alpha.), interleukin-1-beta (IL-1.beta.), and interleukin-2 (IL-2). Also disclosed is a method for substantially purifying the Cytokine Inhibitory Factor and a method for modulating the immune system of an animal using such composition.
Inventor(s): Iyer; Subramanian (Hockessin, DE), Johnson; William L. (Wilmington, DE), Nguyen; Lance (Telford, PA), Ross; Steven C. (Wilmington, DE), Xing; Ruye (Avondale, PA)
Assignee: Arkion Life Sciences, LLC (Wilmington, DE)
Application Number:10/364,593
Patent Claim Types:
see list of patent claims
Composition; Use; Formulation; Dosage form; Delivery; Device; Process;

Drugs Protected by US Patent 7,083,809

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 7,083,809

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Mexico PA04007694 ➤ Try a Free Trial
South Korea 20040105710 ➤ Try a Free Trial
Hong Kong 1080749 ➤ Try a Free Trial
European Patent Office 1487465 ➤ Try a Free Trial
China 1279972 ➤ Try a Free Trial
China 1642562 ➤ Try a Free Trial
Canada 2474360 ➤ Try a Free Trial
Brazil 0307691 ➤ Try a Free Trial
Australia 2003216227 ➤ Try a Free Trial
World Intellectual Property Organization (WIPO) 03068152 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Citi
Dow
US Department of Justice
Harvard Business School
Argus Health
Merck
Boehringer Ingelheim
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot